SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sanofi India informs about change in management

24 Jun 2024 Evaluate
In furtherance of communication dated 1st June 2024 under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 in connection with the Scheme of Arrangement between Sanofi India (Demerged Company) and its wholly owned subsidiary, Sanofi Consumer Healthcare India (Resulting Company) for the demerger of the consumer healthcare undertaking of the Demerged Company with and into the Resulting Company, where the Company informed the effectiveness of the Scheme on 1st June 2024 on account of the filing of the certified true copy of the order of the National Company Law Tribunal dated 7th May 2024, sanctioning the Scheme in Form INC - 28 with the Registrar of Companies, Mumbai, Sanofi India has informed that Himanshu Bakshi, who was previously engaged as the GM - Consumer Healthcare (CHC) business in the Demerged Company is transferred to Resulting Company, in terms of the Scheme. Pursuant to such transfer he has ceased to be a Senior Management Personnel for Demerged Company and is appointed as the Managing Director of the Resulting Company. Due to his appointment requiring the approval of the Board of the Resulting Company, there was a delay in his cessation as a Senior Management Personnel at the Demerged Company. In addition, the Resulting Company has appointed Surendra Agarwal as the Whole-time Director and Chief Financial Officer and Nikunj Savaliya as the Company Secretary & Head of Legal and Compliance Officer of the Resulting Company. A brief profile of each of: (a) Himanshu Bakshi; (b) Surendra Agarwal; and (c) Nikunj Savaliya are annexed.

The above information is a part of company’s filings submitted to BSE.

Sanofi India Share Price

3587.20 8.65 (0.24%)
21-Apr-2026 15:43 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.70
Dr. Reddys Lab 1220.00
Cipla 1232.60
Zydus Lifesciences 928.05
Lupin 2305.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×